VECTIVBIO HOLDING AG

$6.31 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About VECTIVBIO HOLDING AG

VectivBio Holding AG operates as a holding company. The Company, through its subsidiaries, focuses on developing medicines that target the biological root cause of rare conditions to achieve disease-modification. VectivBio Holding serves customers in Switzerland and the United States.

Stock Analysis

last close $6.5
1-mo return -17.8%
3-mo return -38.7%
avg daily vol. 11.33T
52-week high 37.7
52-week low 5.95
market cap. $221M
forward pe -
annual div. -
roe -288.9%
ltg forecast 9.7%
dividend yield -
annual rev. $--
inst own. 78.9%
baraka

Subscribe now for daily local and international financial news

Subscribe